Suppr超能文献

对患有唐氏综合征的年轻人中肌肉减少症标志物的描述性分析。

A descriptive analysis of sarcopenia markers in young adults with down syndrome.

作者信息

Nickerson Brett S, Esco Michael R, Schaefer George, Aguiar Elroy J, Czerwinski Stefan A

机构信息

School of Health and Rehabilitation Sciences, The Ohio State University, Columbus, OH, USA.

Department of Kinesiology, The University of Alabama, Tuscaloosa, AL, USA.

出版信息

Exp Gerontol. 2025 Jan;199:112655. doi: 10.1016/j.exger.2024.112655. Epub 2024 Dec 13.

Abstract

BACKGROUND

Most body composition research in individuals with Down Syndrome (DS) has focused on overweight and obesity. Although limited research has shown muscle mass indexes and physical performance levels of adults with DS are similar to or lower than older adults with sarcopenia, there is still a large gap in the literature regarding sarcopenia.

OBJECTIVE

This brief report provides a comprehensive descriptive analysis of sarcopenia and obesity markers in individuals with DS.

METHODS

Fourteen young adults (age = 26 ± 9 yrs.) with DS (males: n = 6; females: n = 8) had appendicular skeletal muscle mass (ASM) measured with bioimpedance analysis and handgrip strength (HGS) measured with a hand dynamometer (dominant hand). Sarcopenia was computed using the European Working Group on Sarcopenia in Older People revised definition (EWGSOP2).

RESULTS

The BMI for the entire group was 24.41 ± 4.01 kg/m, ranging from 16.21 to 31.31 kg/m, with one participant classified as obese. ASM ranged from 11.33 to 24.41 kg (17.49 ± 4.71 kg), and 64 % of participants fell below the EWGSOP2 criteria for muscle mass. HGS ranged from 8 to 31 kg (20 ± 7 kg), and 57 % of participants fell below the EWGSOP2 criteria for muscular strength. Lastly, 5 of 14 participants (approximately 36 %) had sarcopenia according to the EWGSOP2 definition.

CONCLUSION

An alarming number of young adults with DS had sarcopenia, and low HGS and ASM when using the EWGSOP2 definition. Health professionals are encouraged to screen for sarcopenia in young adulthood rather than deferring it to a later stage in life for individuals with DS.

摘要

背景

大多数针对唐氏综合征(DS)个体的身体成分研究都集中在超重和肥胖方面。尽管有限的研究表明,DS成年人的肌肉质量指数和身体机能水平与患有肌肉减少症的老年人相似或更低,但关于肌肉减少症的文献仍存在很大差距。

目的

本简要报告对DS个体的肌肉减少症和肥胖标志物进行了全面的描述性分析。

方法

14名患有DS的年轻成年人(年龄 = 26±9岁)(男性:n = 6;女性:n = 8)通过生物电阻抗分析测量了四肢骨骼肌质量(ASM),并用握力计(优势手)测量了握力(HGS)。使用欧洲老年人肌肉减少症工作组修订定义(EWGSOP2)计算肌肉减少症。

结果

整个组的体重指数(BMI)为24.41±4.01kg/m²,范围为16.21至31.31kg/m²,有一名参与者被归类为肥胖。ASM范围为11.33至24.41kg(17.49±4.71kg),64%的参与者低于EWGSOP2的肌肉质量标准。HGS范围为8至31kg(20±7kg),57%的参与者低于EWGSOP2的肌肉力量标准。最后,根据EWGSOP2定义,14名参与者中有5名(约36%)患有肌肉减少症。

结论

使用EWGSOP2定义时,数量惊人的DS年轻成年人患有肌肉减少症,且HGS和ASM较低。鼓励健康专业人员在DS个体年轻时筛查肌肉减少症,而不是推迟到生命后期。

相似文献

1
A descriptive analysis of sarcopenia markers in young adults with down syndrome.
Exp Gerontol. 2025 Jan;199:112655. doi: 10.1016/j.exger.2024.112655. Epub 2024 Dec 13.
2
Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition.
Clin Nutr. 2016 Dec;35(6):1557-1563. doi: 10.1016/j.clnu.2016.02.002. Epub 2016 Feb 11.
3
Sarcopenia-related parameters in adults with Down syndrome: A cross-sectional exploratory study.
Exp Gerontol. 2019 May;119:93-99. doi: 10.1016/j.exger.2019.01.028. Epub 2019 Jan 30.
6
Association between different skeletal muscle mass indices, physical function, and inflammation in obese pre-frail older adults.
Arch Gerontol Geriatr. 2024 Mar;118:105289. doi: 10.1016/j.archger.2023.105289. Epub 2023 Nov 26.
7
Body composition parameters and sarcopenia in adults with Down syndrome: a case-control study.
Aging Clin Exp Res. 2024 Mar 29;36(1):81. doi: 10.1007/s40520-023-02680-9.
9
Prevalence of Sarcopenia and Relationships Between Muscle and Bone in Indian Men and Women.
Calcif Tissue Int. 2021 Oct;109(4):423-433. doi: 10.1007/s00223-021-00860-1. Epub 2021 May 9.
10
Circulating myostatin as a biomarker of muscle mass and strength in individuals with cancer or obesity.
Clin Nutr. 2024 Jul;43(7):1800-1808. doi: 10.1016/j.clnu.2024.05.046. Epub 2024 May 31.

本文引用的文献

2
Body composition parameters and sarcopenia in adults with Down syndrome: a case-control study.
Aging Clin Exp Res. 2024 Mar 29;36(1):81. doi: 10.1007/s40520-023-02680-9.
3
Sarcopenia and Sarcopenic Obesity and Mortality Among Older People.
JAMA Netw Open. 2024 Mar 4;7(3):e243604. doi: 10.1001/jamanetworkopen.2024.3604.
4
Deuterium oxide validation of bioimpedance total body water estimates in Hispanic adults.
Front Nutr. 2023 Aug 24;10:1221774. doi: 10.3389/fnut.2023.1221774. eCollection 2023.
5
Evaluation of a Rapid Four-Compartment Model and Stand-Alone Methods in Hispanic Adults.
J Nutr. 2023 Aug;153(8):2154-2162. doi: 10.1016/j.tjnut.2023.06.041. Epub 2023 Jul 5.
6
Cardiometabolic profiles in children and adults with overweight and obesity and down syndrome.
Am J Med Genet A. 2023 Mar;191(3):813-822. doi: 10.1002/ajmg.a.63088. Epub 2022 Dec 20.
7
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement.
Obes Facts. 2022;15(3):321-335. doi: 10.1159/000521241. Epub 2022 Feb 23.
8
Sarcopenia and poor muscle quality associated with severe obesity in young adults and middle-aged adults.
Clin Nutr ESPEN. 2021 Oct;45:299-305. doi: 10.1016/j.clnesp.2021.07.031. Epub 2021 Aug 14.
10
Evidences from Clinical Trials in Down Syndrome: Diet, Exercise and Body Composition.
Int J Environ Res Public Health. 2020 Jun 16;17(12):4294. doi: 10.3390/ijerph17124294.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验